Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroprotection (including hypothermia).

D K Menon1, A C Summors

  • 1Department of Anaesthesiology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. dkm13@wbic.cam.ac.uk

Current Opinion in Anaesthesiology
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with increased radiation exposure in the fixation of proximal femoral fractures.

Annals of the Royal College of Surgeons of England·2024
Same author

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial.

Intensive care medicine·2022
Same author

Cross-tissue immune cell analysis reveals tissue-specific features in humans.

Science (New York, N.Y.)·2022
Same author

Chronic subdural haematoma: the role of peri-operative medicine in a common form of reversible brain injury.

Anaesthesia·2022
Same author

A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuries.

Journal of immunological methods·2021
Same author

Reorganisation of Brain Hubs across Altered States of Consciousness.

Scientific reports·2020
Same journal

Phrenic-sparing strategies for shoulder surgery: balancing respiratory safety and block completeness.

Current opinion in anaesthesiology·2026
Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026
Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026
Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026
Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026
Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026
See all related articles

Neuroprotection research shows promise in areas like inflammation and gene therapy, but clinical success remains limited. This study explores reasons why experimental neuroprotection fails to translate into patient benefits.

Area of Science:

  • Neuroscience
  • Translational Medicine
  • Pharmacology

Background:

  • Over 2000 publications in the past year highlight intense research in neuroprotection.
  • Emerging therapeutic targets include cerebral inflammation, hypothermia, neural transplantation, and gene therapy.

Purpose of the Study:

  • To explore the reasons behind the limited clinical translation of successful experimental neuroprotection strategies.

Main Methods:

  • Literature review and analysis of experimental neuroprotection studies.
  • Comparative analysis of preclinical findings versus clinical trial outcomes.

Main Results:

  • Despite numerous publications, few neuroprotection strategies have achieved clinical success.

Related Experiment Videos

  • Significant gap exists between experimental efficacy and patient benefit.

    • Conclusions:

    • The discrepancy between experimental neuroprotection success and clinical outcomes requires further investigation.
    • Identifying barriers to clinical translation is crucial for advancing neuroprotective therapies.